HKD 0.13
(-2.31%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 153.46 Million HKD | -17.65% |
2022 | 186.34 Million HKD | 37.88% |
2021 | 135.15 Million HKD | -14.57% |
2020 | 158.2 Million HKD | 66.32% |
2019 | 95.11 Million HKD | 250.72% |
2018 | 27.12 Million HKD | -75.52% |
2017 | 110.77 Million HKD | -28.65% |
2016 | 155.24 Million HKD | -50.07% |
2015 | 310.9 Million HKD | 59.61% |
2014 | 194.79 Million HKD | 22.26% |
2013 | 159.33 Million HKD | 459.04% |
2012 | 28.5 Million HKD | -37.47% |
2011 | 45.58 Million HKD | -15.9% |
2010 | 54.19 Million HKD | 321.16% |
2009 | 12.86 Million HKD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 Q4 | 52.96 Million HKD | 0.0% |
2023 FY | 153.46 Million HKD | -17.65% |
2023 Q2 | 78.12 Million HKD | 0.0% |
2022 Q4 | 77.14 Million HKD | 0.0% |
2022 Q2 | 109.19 Million HKD | 0.0% |
2022 FY | 186.34 Million HKD | 37.88% |
2021 Q2 | 71.25 Million HKD | 0.0% |
2021 FY | 135.15 Million HKD | -14.57% |
2021 Q4 | 71.76 Million HKD | 0.0% |
2020 Q4 | 81.75 Million HKD | 0.0% |
2020 Q2 | 76.44 Million HKD | 0.0% |
2020 FY | 158.2 Million HKD | 66.32% |
2019 FY | 95.11 Million HKD | 250.72% |
2019 Q2 | -155 Thousand HKD | 0.0% |
2019 Q4 | 86.21 Million HKD | 0.0% |
2018 Q2 | 18.38 Million HKD | 0.0% |
2018 FY | 27.12 Million HKD | -75.52% |
2018 Q4 | 8.73 Million HKD | 0.0% |
2017 Q2 | 26.25 Million HKD | 0.0% |
2017 FY | 110.77 Million HKD | -28.65% |
2016 FY | 155.24 Million HKD | -50.07% |
2016 Q2 | 113.06 Million HKD | 0.0% |
2015 FY | 310.9 Million HKD | 59.61% |
2015 Q2 | 76.8 Million HKD | 0.0% |
2014 Q2 | 70.26 Million HKD | 0.0% |
2014 FY | 194.79 Million HKD | 22.26% |
2013 Q4 | 104.08 Million HKD | 0.0% |
2013 Q2 | 55.24 Million HKD | 0.0% |
2013 FY | 159.33 Million HKD | 459.04% |
2012 Q4 | 14.89 Million HKD | 3414.15% |
2012 FY | 28.5 Million HKD | -37.47% |
2012 Q1 | 817 Thousand HKD | 0.0% |
2012 Q2 | 817 Thousand HKD | 0.0% |
2012 Q3 | 424 Thousand HKD | -48.1% |
2011 Q4 | 817 Thousand HKD | 0.0% |
2011 Q2 | 5.45 Million HKD | 0.0% |
2011 Q1 | 5.45 Million HKD | 0.0% |
2011 FY | 45.58 Million HKD | -15.9% |
2011 Q3 | 817 Thousand HKD | -85.02% |
2010 Q3 | 5.45 Million HKD | 390.93% |
2010 Q2 | -1.87 Million HKD | 0.0% |
2010 FY | 54.19 Million HKD | 321.16% |
2010 Q1 | -1.87 Million HKD | 0.0% |
2010 Q4 | 5.45 Million HKD | 0.0% |
2009 Q4 | -1.87 Million HKD | 0.0% |
2009 FY | 12.86 Million HKD | 0.0% |
2009 Q3 | -1.87 Million HKD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Natural Beauty Bio-Technology Limited | 204.08 Million HKD | 24.804% |
Innovative Pharmaceutical Biotech Limited | 14.27 Million HKD | -975.123% |
China Overseas Nuoxin International Holdings Limited | 38.32 Million HKD | -300.404% |
Prosperous Future Holdings Limited | 118.15 Million HKD | -29.887% |
Fourace Industries Group Holdings Limited | 57.65 Million HKD | -166.17% |
Evergreen Products Group Limited | 152.17 Million HKD | -0.849% |
EC Healthcare | 597.44 Million HKD | 74.314% |
Ming Fai International Holdings Limited | 357.68 Million HKD | 57.095% |
Blue Moon Group Holdings Limited | 4.4 Billion HKD | 96.52% |
SuperRobotics Holdings Limited | 15.16 Million HKD | -912.222% |
Takbo Group Holdings Limited | 65.71 Million HKD | -133.517% |
Hyfusin Group Holdings Limited | 196.91 Million HKD | 22.064% |